Herd-level association between antimicrobial use and antimicrobial resistance in bovine mastitis Staphylococcus aureus isolates on Canadian dairy farms

Journal of Dairy Science

Volumn 95, Issue 4, 2012, Pages 1921-1929

  Saini, V ^a,b   McClure, J T ^b,c   Scholl, D T ^b,d   DeVries, T J ^b,e   Barkema, H W ^a,b,f  

^a UNIVERSITY OF CALGARY   (Canada)

^b Canadian Bovine Mastitis Research Network   (Canada)

^c UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF GUELPH   (Canada)

^f GHENT UNIVERSITY   (Belgium)

Author keywords

Antimicrobial resistance; Antimicrobial use; Mastitis; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; DRUG DERIVATIVE; PIRLIMYCIN;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; BOVINE MASTITIS; CANADA; CATTLE; CYTOLOGY; DAIRYING; DRUG EFFECT; FEMALE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MILK; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

AMPICILLIN RESISTANCE; ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; CANADA; CATTLE; CLINDAMYCIN; DAIRYING; DRUG RESISTANCE, BACTERIAL; FEMALE; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS; MILK; PENICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TETRACYCLINE RESISTANCE;

BOVINAE; STAPHYLOCOCCUS AUREUS;

EID: 84858973925     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2011-5065     Document Type: Article

References (45)

1. Acar J.F., Moulin G. Antimicrobial resistance at farm level. Rev. Sci. Tech. 2006, 25:775-792.
2. Baggot J.D. Principles of antimicrobial drug bioavailability and disposition. Antimicrobial Therapy in Veterinary Medicine 2006, 65. Blackwell Publishing, Ames, IA. S. Giguère (Ed.).
3. Barkema H.W., Schukken Y.H., Lam T.J.G.M., Beiboer M.L., Wilmink H., Benedictus G., Brand A. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. J. Dairy Sci. 1998, 81:411-419.
4. Barkema H.W., Schukken Y.H., Lam T.J., Beiboer M.L., Benedictus G., Brand A. Management practices associated with the incidence rate of clinical mastitis. J. Dairy Sci. 1999, 82:1643-1654.
5. Barkema H.W., Schukken Y.H., Zadoks R.N. Invited review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J. Dairy Sci. 2006, 89:1877-1895.
6. CLSI (Clinical and Laboratory Standards Institute). 2008. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Approved Standard. 3rd ed. M31-A3: 65-72.
7. Dohoo I.R., Martin W., Stryhn H. Veterinary Epidemiologic Research 2009, VER Inc, Charlottetown, PEI, Canada. 2nd ed.
8. Erskine R.J., Wagner S., DeGraves F.J. Mastitis therapy and pharmacology. Vet. Clin. North Am. Food Anim. Pract. 2003, 19:109-138.
9. Erskine R.J., Walker R.D., Bolin C.A., Bartlett P.C., White D.G. Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period. J. Dairy Sci. 2002, 85:1111-1118.
10. FINRES-Vet. 2007. Finnish Veterinary Antimicrobial Resistance Monitoring and Consumption of Antimicrobial Agents, 2005-2006. Finnish Food Safety Authority Evira, Helsinki, Finland. Accessed Oct. 19, 2011. http://www.evira.fi/portal/en/evira/publications/%3Fa=view%26productId=178.
11. Guardabassi L., Courvalin P. Modes of antimicrobial action and mechanisms of bacterial resistance. Antimicrobial Resistance in Bacteria of Animal Origin 2006, 5. American Society of Microbiology, Washington, DC. F.M. Aarestrup (Ed.).
12. Güler L., Ok Ü., Gündüz K., Gülcü Y., Hadimli H.H. Antimicrobial susceptibility and coagulase gene typing of Staphylococcus aureus isolated from bovine clinical mastitis cases in Turkey. J. Dairy Sci. 2005, 88:3149-3154.
13. Hillerton J.E., Berry E.A. Treating mastitis in the cow-A tradition or an archaism. J. Appl. Microbiol. 2005, 98:1250-1255.
14. Hogan J.S., Gonzalez R.N., Harmon R., Nickerson S.C., Oliver S.P., Pankey J.W., Smith K.L. Laboratory Handbook on Bovine Mastitis 1999, National Mastitis Council Inc., Verona, WI.
15. Hosmer D.W., Lemeshow S. Applied logistic regression 2000, John Wiley & Sons Inc., Hoboken, NJ. 2nd ed.
16. Jensen V.F., Jacobsen E., Bager F. Veterinary antimicrobial-usage statistics based on standardized measures of dosage. Prev. Vet. Med. 2004, 64:201-215.
17. Kirk J.H., McCowan B., Atwill E.R., Glenn K.S., Higginbotham G.E., Collar C.A., Castillo A., Reed B.A., Peterson N.G., Cullor J.S. Association of minimum inhibitory concentration cluster patterns with dairy management practices for environmental bacteria isolated from bulk tank milk. J. Dairy Sci. 2005, 88:3710-3720.
18. Levy S.B., Marshall B. Antibacterial resistance worldwide: Causes, challenges and responses. Nat. Med. 2004, 10:S122-S129.
19. Makovec J.A., Ruegg P.L. Antimicrobial resistance of bacteria isolated from dairy cow milk samples submitted for bacterial culture: 8,905 samples (1994-2001). J. Am. Vet. Med. Assoc. 2003, 222:1582-1589.
20. Marshall A.B., Palmer G.H. Injection sites and drug bioavailability. Trends in Veterinary Pharmacology and Toxicology 1980, 54. Elsevier Publishing Company, Amsterdam, the Netherlands. A.S.J.P.A.M. Van Miert (Ed.).
21. Mitchell J.M., Griffiths M.W., McEwen S.A., McNab W.B., Yee A.J. Antimicrobial drug residues in milk and meat: Causes, concerns, prevalence, regulations, tests, and test performance. J. Food Prot. 1998, 61:742-756.
22. Olde Riekerink R.G.M., Barkema H.W., Kelton D.F., Scholl D.T. Incidence rate of clinical mastitis on Canadian dairy farms. J. Dairy Sci. 2008, 91:1366-1377.
23. Østerås O., Martin S.W., Edge V.L. Possible risk factors associated with penicillin-resistant strains of Staphylococcus aureus from bovine subclinical mastitis in early lactation. J. Dairy Sci. 1999, 82:927-938.
24. Piepers S., De Meulemeester L., de Kruif A., Opsomer G., Barkema H.W., De Vliegher S. Prevalence and distribution of mastitis pathogens in subclinically infected dairy cows in Flanders, Belgium. J. Dairy Res. 2007, 74:478-483.
25. Pol M., Ruegg P.L. Relationship between antimicrobial drug usage and antimicrobial susceptibility of gram-positive mastitis pathogens. J. Dairy Sci. 2007, 90:262-273.
26. Prescott F.J. Beta-lactam antibiotics: Penam penicillins. antimicrobial therapy in veterinary medicine 2006, 127. Blackwell Publishing, Ames, IA. S. Giguère (Ed.).
27. Rajala-Schultz P.J., Smith K.L., Hogan J.S., Love B.C. Antimicrobial susceptibility of mastitis pathogens from first lactation and older cows. Vet. Microbiol. 2004, 102:33-42.
28. Reyher K.K., Dufour S., Barkema H.W., Des Côteaux L., Devries T.J., Dohoo I.R., Keefe G.P., Roy J.-P., Scholl D.T. The National Cohort of Dairy Farms-A data collection platform for mastitis research in Canada. J. Dairy Sci. 2011, 94:1616-1626.
29. Roberson J.R., Fox L.K., Hancock D.D., Gay J.M., Besser T.E. Sources of intramammary infections from Staphylococcus aureus in dairy heifers at first parturition. J. Dairy Sci. 1998, 81:687-693.
30. Roesch M., Perreten V., Doherr M.G., Schaeren W., Schällibaum M., Blum J.W. Comparison of antibiotic resistance of udder pathogens in dairy cows kept on organic and on conventional farms. J. Dairy Sci. 2006, 89:989-997.
31. Sabour P.M., Gill J.J., Lepp D., Pacan J.C., Ahmed R., Dingwell R., Leslie K. Molecular typing and distribution of Staphylococcus aureus isolates in Eastern Canadian dairy herds. J. Clin. Microbiol. 2004, 42:3449-3455.
32. Saini V., McClure J.T., Léger D., Dufour S., Sheldon A.G., Scholl D.T., Barkema H.W. Antimicrobial use on Canadian dairy farms. J. Dairy Sci. 2012, 95:1209-1221. doi:10.3168/jds.2011-4527.
33. Saini V., Olde Riekerink R.G.M., McClure J.T., Barkema H.W. Diagnostic accuracy assessment of Sensititre and agar disk diffusion for determining antimicrobial resistance profiles of bovine clinical mastitis pathogens. J. Clin. Microbiol. 2011, 49:1568-1577.
34. Sampimon O., Barkema H.W., Berends I., Sol J., Lam T. Prevalence of intramammary infection in Dutch dairy herds. J. Dairy Res. 2009, 76:129-136.
35. Schwarz S., Chaslus-Dancla E. Use of antimicrobials in veterinary medicine and mechanisms of resistance. Vet. Res. 2001, 32:201-225.
36. Silbergeld E.K., Graham J., Price L.B. Industrial food animal production, antimicrobial resistance, and human health. Annu. Rev. Public Health 2008, 29:151-169.
37. Sol J., Sampimon O.C., Barkema H.W., Schukken Y.H. Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. J. Dairy Sci. 2000, 83:278-284.
38. Tikofsky L.L., Barlow J.W., Santisteban C., Schukken Y.H. A comparison of antimicrobial susceptibility patterns for Staphylococcus aureus in organic and conventional dairy herds. Microb. Drug Resist. 2003, 9:S39-S45.
39. Waage S. Comparison of two regimens for the treatment of clinical bovine mastitis caused by bacteria sensitive to penicillin. Vet. Rec. 1997, 141:616-620.
40. Wang Y., Wu C.-M., Lu L.-M., Ren G.-W.N., Cao X.-Y., Shen J.-Z. Macrolide-lincosamide-resistant phenotypes and genotypes of Staphylococcus aureus isolated from bovine clinical mastitis. Vet. Microbiol. 2008, 130:118-125.
41. Watts J.L., Salmon S.A. Activity of selected antimicrobial agents against strains of Staphylococcus aureus isolated from bovine intramammary infections that produce β-lactamase. J. Dairy Sci. 1997, 80:788-791.
42. Werckenthin C., Cardoso M., Martel J.-L., Schwarz S. Antimicrobial resistance in staphylococci from animals with particular reference to bovine Staphylococcus aureus, porcine Staphylococcus hyicus, and canine Staphylococcus intermedius. Vet. Res. 2001, 32:341-362.
43. White D.G., McDermott P.F. Emergence and transfer of antibacterial resistance. J. Dairy Sci. 2001, 84:E151-E155.
44. Recommendations in WHO Proceedings: The Medical Impact of Antimicrobial use in Food Animals. WHO/EMC/ZOO/97.4, 1997 1997, WHO (World Health Organization), WHO, Geneva, Switzerland, Pages 11-16.
45. Ziv G., Storper M. Intramuscular treatment of subclinical staphylococcal mastitis in lactating cows with penicillin G, methicillin and their esters. J. Vet. Pharmacol. Ther. 1985, 8:276-283.